Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.
| Class:Id | LiteratureReference:9980275 |
|---|---|
| _displayName | Covalent modification by SUMO is required for efficient disruption of PML oncogenic domains by Kaposi's sarcoma-associated herpesvirus latent protein LANA2 |
| _timestamp | 2026-01-27 08:46:16 |
| author | [Person:9682830] Marcos-Villar, Laura [Person:9834793] Campagna, Michela [Person:3214991] Lopitz-Otsoa, Fernando [Person:9966209] Gallego, Pedro [Person:9966211] González-Santamaría, José [Person:9966210] González, Dolores [Person:3000376] Rodriguez, Manuel S [Person:8943534] Rivas, Carmen |
| created | [InstanceEdit:9980276] Stephan, Ralf, 2026-01-27 |
| journal | J Gen Virol |
| pages | 188-94 |
| pubMedIdentifier | 20881090 |
| title | Covalent modification by SUMO is required for efficient disruption of PML oncogenic domains by Kaposi's sarcoma-associated herpesvirus latent protein LANA2 |
| volume | 92 |
| year | 2011 |
| (literatureReference) | [BlackBoxEvent:9980271] vIRF-3 is sumoylated [Homo sapiens] |
| [Change default viewing format] | |